Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 146Carcinoma, Non-Small-Cell Lung 112Carcinoma, Renal Cell 74Neoplasm Metastasis 53Carcinoma, Hepatocellular 51Squamous Cell Carcinoma of Head and Neck 50Lung Neoplasms 48Colorectal Neoplasms 34Pancreatic Neoplasms 30Neoplasms 30Hodgkin Disease 30Urinary Bladder Neoplasms 24Sarcoma 23Brain Neoplasms 23Stomach Neoplasms 22Head and Neck Neoplasms 21Breast Neoplasms 21Prostatic Neoplasms 20Carcinoma, Transitional Cell 20Glioblastoma 19Recurrence 17Colonic Neoplasms 17Kidney Neoplasms 16Uveal Melanoma 15Small Cell Lung Carcinoma 15Multiple Myeloma 15Esophageal Neoplasms 15Carcinoma, Squamous Cell 14Skin Neoplasms 13Leukemia, Myeloid, Acute 13

Interventions

pembrolizumab 2perflutren 1Vinorelbine 1Thoracoscopy 1Surveys and Questionnaires 1Sulfur Hexafluoride 1Radiotherapy 1Prednisone 1Pemetrexed 1Paclitaxel 1Nivolumab 1Immune Checkpoint Inhibitors 1Hypnosis 1Health Records, Personal 1Gemcitabine 1Drug Therapy 1Dexamethasone 1Conscious Sedation 1Clinical Protocols 1Carboplatin 1Bronchoscopy 1Bronchoalveolar Lavage 1Blood Pressure 1Bevacizumab 1Behavior Therapy 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lung Diseases, Interstitial × Nivolumab × Clear all
NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
108 enrolled

Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡